IRB Barcelona logo

News

Highlighting IRB Barcelona's impact on society

News

Ernest Giralt and Teresa Tarragó, researchers at IRB Barcelona and the UB, and founders of Iproteos.
Institutional
Launch of Iproteos, a company devoted to the discovery of next-generation drugs
irbbarcelona
Scientific
The dancing amino acids of ubiquitin
Smad region (in blue) bound to the protein that causes its degradation after gene activation (in gray).
Scientific
Discovery of a new mechanism of gene control that is associated with cancer
Proteins with disulphide bridges form more stable and less toxic fibers that those that do not have these bridges.
Scientific
The fight against the toxic aggregation of proteins according to Darwin
3rd Career Progression in Science Day speakers
Institutional
More than 60 participants take part in the 3rd Career Progression in Science Day
Scientific
Spanish scientists sequence the genome for chronic lymphocytic leukemia
Antonio Zorzano at IRB Barcelona
Institutional
Antonio Zorzano receives the Alberto Sols Senior Investigator Award for Basic Research
Modesto Orozco at IRB Barcelona
Institutional
IRB Barcelona to collaborate with the private sector to study new painkillers for patients with arthrosis and to design diagnostic tools for other diseases
Institutional
NIH of the United States to finance a large-scale cancer genetics project undertaken by IRB Barcelona

Media Mentions

Blog

Do you want to be informed?

Visit our blog.

IRB Blog